Did you mean pain?
Overview
Lynparza is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat metastatic breast cancer. Lynparza may be prescribed for either hormone receptor-positive or -negative cases,… read more
Overview
Talzenna is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat adults with HER2-negative and germline BRCA-mutated breast cancer that is metastatic or locally advanced.… read more